Lilly Says Patent Suit Isn’t Valid: Eli...
From Times Staff and Wire Service Reports
Lilly Says Patent Suit Isn’t Valid: Eli Lilly & Co. said a patent infringement suit filed against the company by the University of California Regents has no merit. The Indianapolis-based pharmaceuticals company said it “carefully evaluated” the university’s patent for the biotechnology to make human insulin and “determined that it was not valid.”
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
